|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: INKINE PHARMACEUTICAL CO INC, 8-K, 1998-02-09 |
Next: INKINE PHARMACEUTICAL CO INC, 4, 1998-02-09 |
<PAGE> 1
- ----------------------- -----------------------------
FORM 4 OMB APPROVAL
- ----------------------- -----------------------------
[ ] Check this box if no longer OMB NUMBER 3235-0287
subject to Section 16. Form 4 EXPIRES: SEPTEMBER 30, 1998
or Form 5 obligations may ESTIMATED AVERAGE BURDEN
continue. See Instruction 1(b) HOURS PER RESPONSE.....0.5
-----------------------------
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section
17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the
Investment Company Act of 1940
(Print or Type Responses)
- --------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
Weisbach, Ph.D. Jerry
- --------------------------------------------------------------------------------
(Last) (First) (Middle)
InKine Pharmaceutical Company, Inc.
Sentry Park East
1720 Walton Road
- --------------------------------------------------------------------------------
(Street)
Blue Bell, Pennsylvania 19422
- --------------------------------------------------------------------------------
(City) (State) (Zip)
- --------------------------------------------------------------------------------
2. Issuer Name and Ticker or Trading Symbol
InKine Pharmaceutical Company, Inc. (INKP)
- --------------------------------------------------------------------------------
3. IRS or Social Security Number of Reporting Person (Voluntary)
- --------------------------------------------------------------------------------
4. Statement for Month/Year
1/98
- --------------------------------------------------------------------------------
5. If Amendment, Date of Original (Month/Year)
- --------------------------------------------------------------------------------
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
[ x ] Director [ ] 10% Owner
[ ] Officer (give title below) [ ] Other (specify below)
- --------------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
[ X ] Form filed by One Reporting Person
[ ] Form filed by More than One Reporting Person
- --------------------------------------------------------------------------------
TABLE I -- NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY
OWNED
<TABLE>
<CAPTION>
- -----------------------------------------------------------------------------------------------------------------------------------
1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired (A) or 5. Amount of 6. Owner- 7. Nature
(Instr. 3) action Date action Disposed of (D) Securities ship of In-
Code (Instr. 3, 4 and 5) Beneficially Form: direct
(Month/ (Instr. 8) Owned at Direct Bene-
Day/ End of (D) or ficial
Year) Month Indirect Owner-
(Instr. 3 (Instr.4) ship
and 4) (Instr.4)
----------------------------------------------
(A) or
Code V Amount (D) Price
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction
4(b)(v).
(Over)
SEC 1474 (7-96)
<PAGE> 2
FORM 4 (CONTINUED)
TABLE II - DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
(E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
<TABLE>
<CAPTION>
- -------------------------------------------------------------------------------------------------------------------
1. Title of Derivative Security 2. Conver- 3. Trans- 4. Transac-
(Instr. 3) sion or action Date tion Code
Exercise (Month/Day/Year) (Instr. 8)
Price of
Deriv-
ative
Security
-------------------------
Code V
- -------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Stock Option (Right to Buy) $1.00 1/29/98 A
- -------------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------------
</TABLE>
<TABLE>
<CAPTION>
- -----------------------------------------------------------------------------------------------------------------------------------
5. Number of Deriv- 6. Date Exercisable and 7. Title and Amount of
ative Securities Expiration Date Underlying Securities
Acquired (A) or (Month/Day/Year) (Instr. 3 and 4)
Disposed of (D)
(Instr. 3, 4 and 5)
------------------------------------------------------------------------------------------
Date Expira- Amount or Number
Exer- tion Title of Shares
cisable Date
- ---------------------------------------
(A) (D)
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
37,500 * 1/29/08 Common Stock 37,500
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
<TABLE>
<CAPTION>
- ------------------------------------------------------------------------------------------------------
8. Price 9. Number 10. Ownership 11. Nature of
of of Derivative of Derivative Indirect
Derivative Securities Security: Beneficial
Security Beneficially Direct (D) Ownership
(Instr. 5) Owned or Indirect (I) (Instr. 4)
at End (Instr. 4)
of Month
(Instr. 4)
- ------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
37,500 D
- ------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------
</TABLE>
EXPLANATION OF RESPONSES:
* Option became exerciseable as to 7,500 shares on January 29, 1998.
It will become exerciseable with respect to the balance of the
shares in annual increments of 7,500 shares commencing on January
29, 1999.
** INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACTS CONSTITUTE FEDERAL
CRIMINAL VIOLATIONS.
SEE 18 U.S.C. 1001 AND 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If
space provided is insufficient, see Instruction 6 for procedure.
POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION CONTAINED
IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS A
CURRENTLY VALID OMB NUMBER.
/s/ JERRY WEISBACH, PH.D. 2/9/98
----------------------------------------- --------------
** SIGNATURE OF REPORTING PERSON DATE
Page 2
SEC 1474 (7-96)
|
|